Literature DB >> 31760067

Isosteroid alkaloids from Fritillaria cirrhosa bulbus as inhibitors of cigarette smoke-induced oxidative stress.

Simei Liu1, Tiechui Yang2, Tse Wai Ming2, Tse Kathy Wai Gaun2, Ting Zhou1, Shu Wang1, Bengui Ye3.   

Abstract

Fritillaria cirrhosa bulbus is a Chinese folk herb famous for its antitussive, expectorant, anti-asthma and anti-inflammatory properties, and is widely used to treat respiratory diseases. However, the impacts of F. cirrhosa bulbus on oxidative stress are still unkown. In the present study, we investigated the potential effect and mechanism of six isosteroid alkaloids with different chemical structures from F. cirrhosa bulbus on protection against cigarette smoke-induced oxidative stress in RAW264.7 macrophages. The results showed that six isosteroid alkaloids reduced reactive oxygen species (ROS) production, elevated glutathione (GSH) level and promoted heme oxygenase (HO-1) expression, which is in association with induction of NF-E2-related factor 2 (Nrf2) nuclear translocation and up-regulation of Nrf2 expression. Among these alkaloids, verticinone, verticine, imperialine-3-β-D-glucoside, delavine and peimisine exhibited more potent effect against CSE-induced oxidative stress than that of imperialine. These findings for the first time demonstrated that F. cirrhosa bulbus may play a protective role in cellular oxidative stress by activating Nrf2-mediated antioxidant pathway. Furthermore, the differences in antioxidant effects of these alkaloids were compared, as well as the corresponding structure-activity relationships were preliminarily elucidated. This suggested that F. cirrhosa bulbus might be a promising therapeutic treatment for the prevent of oxidative stress-related diseases.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fritillaria cirrhosa bulbus; HO-1; Isosteroid alkaloids; Macrophages; Nrf2; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31760067     DOI: 10.1016/j.fitote.2019.104434

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  6 in total

Review 1.  A Systematic Review on Traditional Uses, Sources, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Fritillariae Cirrhosae Bulbus.

Authors:  Ting Chen; Furong Zhong; Cheng Yao; Jia Chen; Yiqing Xiang; Jijing Dong; Zhuyun Yan; Yuntong Ma
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-12       Impact factor: 2.629

Review 2.  Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses.

Authors:  Ye Wang; Hongping Hou; Qiang Ren; Haoyu Hu; Tiechui Yang; Xiwen Li
Journal:  Chin Med       Date:  2021-05-31       Impact factor: 5.455

Review 3.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

4.  Integrative analysis of the steroidal alkaloids distribution and biosynthesis of bulbs Fritillariae Cirrhosae through metabolome and transcriptome analyses.

Authors:  Qiuxia Lu; Rui Li; Jiaqing Liao; Yuqin Hu; Yundong Gao; Mingcheng Wang; Jian Li; Qi Zhao
Journal:  BMC Genomics       Date:  2022-07-14       Impact factor: 4.547

5.  Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38/Akt/STAT6 signals.

Authors:  Ze-Hui Cai; Yan-Ge Tian; Jun-Zi Li; Peng Zhao; Jian-Sheng Li; Xue Mei; Yun-Ping Bai
Journal:  Biosci Rep       Date:  2022-10-28       Impact factor: 3.976

Review 6.  Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Authors:  Parteek Prasher; Mousmee Sharma; Meenu Mehta; Keshav R Paudel; Saurabh Satija; Dinesh K Chellappan; Harish Dureja; Gaurav Gupta; Murtaza M Tambuwala; Poonam Negi; Peter R Wich; Nicole G Hansbro; Philip M Hansbro; Kamal Dua
Journal:  Chem Biol Interact       Date:  2020-05-04       Impact factor: 5.192

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.